NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Type 2 Diabetes Mellitus
Date of first enrollment	18/04/2011
Target sample size
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : Dapagliflozin INN of investigational material : Therapeutic category code : 396 Antidiabetic agents Dosage and Administration for Investigational material : 5mg or 10mg, Oral Dose

Outcome(s)

Primary Outcome
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	>= 20age old
Age maximum	Not applicable
Gender	Both
Include criteria	- Provision of informed consent prior to any study specific procedures - Men or women age 20 years old or more (Either gender needs to be 40% or higher of total number of treated subjects) - diagnosed with type2 DM
Exclude criteria	- Type 1 diabetes mellitus - FPG more than 240 mg/dL before treatment started - Subjects who have history of unstable or rapidly progressing renal disease - Subjects who have severe hepatic insufficiency and/or significant abnormal liver function - Significant cardiovascular history